Home / People / Sam Fisher

Sam Fisher

Associate

Portrait ofSam Fisher

Sam Fisher

Associate

Contact
CMS Cameron McKenna Nabarro Olswang LLP
Cannon Place
78 Cannon Street
London
EC4N 6AF
United Kingdom
Languages English

Sam is an Associate Solicitor in CMS’ Intellectual Property team in London. He advises clients principally in the biotechnology, technology and media sectors, on a range of hard and soft IP and connected commercial issues. He has experience litigating in the High Court, Court of Appeal and at the Intellectual Property Office.

Prior to his legal career, Sam spent eight years managing trade mark licensing campaigns as well as at a biotechnology start-up.

more less

Education

  • 2020 - Postgraduate Diploma in Intellectual Property Law, University of Oxford, Oxford.
  • 2015 – Master of Arts (Legal Practice Course with Business), BPP University, London.
  • 2014 – Graduate Diploma in Law, BPP University, London.
  • 2008 – Batchelor of Science (Hons), University of Nottingham, Nottingham.
more less

Expertise

Feed

06/05/2024
Transfer of IP rights in the United Kingdom
Pat­ents: As­sign­ment 1. How may a patent be assigned (by law and/or transaction) and is it required to record the assignment in the national patent register to become effective?  A patent can be transferred...
Expert Guide Intellectual Property
Comparable
22/12/2023
High Court dismisses summary judgment application in Getty Images v Stability...
The High Court has recently handed down judgment on Stability AI’s application for reverse summary judgment and strike out in the high-profile Getty Images v Stability AI litigation. Earlier this year...
Law-Now Media
27/09/2023
My Computer did it! Exploring SHEIN’s latest lawsuit
In the latest of a series of copyright infringement claims, three independent graphic designers - Krista Perry, Larissa Martinez, and Jay Baron, have launched a claim in the California Federal Court ...
Law-Now Consumer Products
01/11/2021
MHRA encourages e-cigarette manufacturers to obtain UK marketing authorisations
The MHRA has issued guidance encouraging electronic cigarettes and other inhaled nicot­ine-con­tain­ing products to be licensed as medicines and medical devices (in the case of refillable e-cigarettes) in...
Law-Now Life Sciences & Healthcare